Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented ...

The FDA has approved Pfizer’s marstacimab under the brand name Hympavzi for adults and children with hemophilia A or B, ...

MDClone's Luz Erez talks about the company's work with synthetic data and its partnership with Cloudera at Cloudera Evolve 2024.